Clinical Trials Browser

Mastocytosis, Systemic × midostaurin × Myeloid × Clear all

NCT05219266 2024-06-28

Managed Access Programs for PKC412, Midostaurin

No longer available

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Mast-Cell, Leukemia, Myeloid, Acute, Mastocytosis, Systemic

NCT00782067 2018-11-15

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Phase 2 Completed

116 enrolled 16 charts

LymphoidMyeloidOther hematologic neoplasm

Aggression, Leukemia, Leukemia, Mast-Cell, Mastocytosis, Systemic

NCT00233454 2018-09-20

Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia

Phase 2 Completed

26 enrolled 12 charts

LymphoidMyeloidOther hematologic neoplasm

Aggression, Leukemia, Mast-Cell, Mastocytosis, Systemic

NCT01920204 2015-01-19

Midostaurin in Indolent Systemic Mastocytosis

Phase 2 Unknown

Mastocytosis, Mastocytosis, Systemic